慢性阻塞性肺疾病全球倡议 (GOLD) 发布了 2024 年慢性阻塞性肺疾病 (COPD) 诊断、管理和预防报告。 Claus F Vogelmeier(菲利普斯马尔堡大学,德国肺部研究中心,德国马尔堡)在 2023 年 11 月的 GOLD 国际慢性阻塞性肺病会议上讨论了报告中的关键变化。 2023 年 GOLD 董事会主席 Alvar Agusti(西班牙巴塞罗那巴塞罗那大...
近日,慢性阻塞性肺疾病(COPD)全球创议(global initiative for chronic obstructive lung disease,GOLD)2024指南正式发布,总体来说,GOLD 2024版与2023版大致相同,重点在以下部分进行了增添和更新: ➢GOLD 2024报告文末列出了新增的148个参考文献;所有参考文献...
The 2024 COPD GOLD Report: A Guideline Topline, Part 1Bender, KennethPatient Care (Online)
November 28th 2024 2025 GOLD Report: New Insights on COPD Risks, Management Tim Smith The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk, and pulmonary hypertension. November 26th 2024 ...
2.5.8 Diagnosed prevalent cases of COPD by GOLD 2023 criteria using CAT score 2.6 Discussion 2.6.1 Epidemiological forecast insight 2.6.2 COVID-19 impact. 2.6.3 Limitations of the analysis 2.6.4 Strengths of the analysis 3 App...
November 14, 2024 6 min read Save 2025 GOLD report addresses cardiovascular risk, climate change, pulmonary hypertension PHILADELPHIA — To reflect developments in COPD research and care, the 2025 Global Initiative for Chronic Obstructive Lung Disease report features three new sections and several sectio...
Global Initiative for Chronic Obstructive Lung Disease. GOLD 2024 Report. Available at https://goldcopd.org/2024-gold-report/. Accessed on 19 July 2024. Diab N, et al. Am J Respir Crit Care Med 2018;198:1130–1139. Kunisaki KM, et al. Am J Respir Crit Care Med 2018;198:51-57.Foll...
2024 GOLD report: global strategy for prevention, diagnosis and management of COPD: 2024 report. Accessed October 11, 2024. https://goldcopd.org/2024-gold-report/ 3. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic...
Spirometry, treatments, telemedicine and multimorbidity are notable topics at this year’s GOLD International COPD Conference. Updates made in the 2025 GOLD report will also be shared at this event. The 2024 GOLD International COPD Conference will be held Nov. 11 and 12 in Philadelphi...
此外,2024 年《慢性阻塞性肺疾病诊断、治疗和预防全球策略报告(GOLD)》指出[5],β1 受体阻滞剂可以提高心衰患者的生存,推荐用于心衰合并 COPD 的患者中。对于有心血管疾病指征的 COPD 患者,应该使用选择性 β1 受体阻滞剂,如比索洛尔。 ✩ 本文仅供医...